Literature DB >> 6162706

Recurrent pancreatitis induced by valproic acid. A case report and review of the literature.

P H Parker, G L Helinek, F K Ghishan, H L Greene.   

Abstract

Valproic acid represents a new class of anticonvulsants that are widely employed in the management of many types of seizure disorders. Compared with other anticonvulsants, it has been considered relatively free of adverse effects. Recently, acute hepatic failure has been ascribed to valproic acid. Now experience is accumulating that implicates this agent in causing pancreatitis. Contributing to this evidence, the patient described herein had well-documented, recurrent pancreatitis while he was taking valproic acid. Nonspecific vomiting and abdominal pain frequently occur with valproic acid; however, pancreatitis must be considered whenever these symptoms are severe or protracted.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6162706

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Acute pancreatitis in propionic acidaemia.

Authors:  A B Burlina; C Dionisi-Vici; S Piovan; I Saponara; A Bartuli; G Sabetta; F Zacchello
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

2.  Decreased serum carnitine in valproate induced Reye syndrome.

Authors:  H Böhles; K Richter; E Wagner-Thiessen; H Schäfer
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

Review 3.  Adverse reactions in children. Special considerations in prevention and management.

Authors:  P M Leary
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

Review 4.  Valproic acid-induced pancreatitis: 16 new cases and a review of the literature.

Authors:  Thorsten Gerstner; Deike Büsing; Nellie Bell; Elke Longin; Johannes-Martin Kasper; Wolfgang Klostermann; Burkhard Hebing; Folker Hanefeld; Ulrich Eckel; Reiner Hoffmann; Ulrich Bettendorf; Birgit Weidner; Adelheid Wiemer-Kruel; Knut Brockmann; Fritz-Wilhelm Neumann; Thorsten Sandrieser; Markus Wolff; Stephan König
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

Review 5.  Drug-induced pancreatitis.

Authors:  T Wilmink; T W Frick
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

6.  Abnormal metabolism of valproic acid in fatal hepatic failure.

Authors:  W Kochen; A Schneider; A Ritz
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

7.  Pancreatitis during sodium valproate treatment.

Authors:  L H Williams; R P Reynolds; J L Emery
Journal:  Arch Dis Child       Date:  1983-07       Impact factor: 3.791

Review 8.  Drug-induced pancreatitis : incidence, management and prevention.

Authors:  Anil R Balani; James H Grendell
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Acute pancreatitis in six non-transplanted uraemic children. A co-operative study from the French Society of Paediatric Nephrology.

Authors:  B Boudailliez; J L André; M Broyer; J C Davin; G Landthaler; J B Palcoux
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

Review 10.  Ever-increasing diversity of drug-induced pancreatitis.

Authors:  Simcha Weissman; Muhammad Aziz; Ryan B Perumpail; Tej I Mehta; Rutwik Patel; James H Tabibian
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.